Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|August 13, 2015
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinomaRalph T H Leijenaar, Sara Carvalho, Frank J P Hoebers, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 2010
Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinomaChristiaan M Stevens, Shao Hui Huang, Sharon Fung, et al.
Head & Neck|April 28, 2020
Considerations for head and neck oncology practices during the coronavirus disease 2019 (COVID-19) pandemic: Wuhan and Toronto experienceVincent Wu, Christopher W Noel, David Forner, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 11, 2024
Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled TrialJohn R de Almeida, Rosemary Martino, Ali Hosni, et al.
Head & Neck|March 5, 2014
Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancerGary Mok, Isabelle Gauthier, Haiyan Jiang, et al.
The British Journal of Radiology|February 17, 2018
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter studyRalph Th Leijenaar, Marta Bogowicz, Arthur Jochems, et al.
Oral Oncology|January 28, 2021
Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinomaAvinash Pilar, Eugene Yu, Jie Su, et al.
Oral Oncology|August 22, 2024
The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-)radiotherapySulaiman Alsheikh, Jie Su, Brian O'Sullivan, et al.
Oral Oncology|February 13, 2023
The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosisYashi Ballal, Maru Gete, Jie Su, et al.
JAMA Network Open|June 2, 2023
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled TrialNancy Y Lee, Jonathan Harris, John Kim, et al.
Pageof 5